Trajan Group Holdings Ltd (ASX:TRJ) returned to market focus following a sizeable one-day rise. The shares closed at AUD 0.245, up 11.36%, on turnover of AUD 1,999. Its market value was approximately AUD 37.45 million, while the 12-month performance measured -66.89%. The company is …
A late-session re-rating brought Nova Eye Medical Ltd (ASX:EYE) onto investor watchlists. The shares closed at AUD 0.125, up 8.70%, on turnover of AUD 18,125. Its market value was approximately AUD 35.61 million, while the 12-month performance measured -10.71%. The company is a medical-device …
Clinuvel Pharmaceuticals Ltd (ASX:CUV) finished trading on 20 July 2026 at AUD 10.24, rising 3.23%, or AUD 0.32, during the session. Although the stock recorded a solid daily gain, it remains 12.93% lower over the past year, reflecting the longer-term challenges that have affected …
Recce Pharmaceuticals (ASX:RCE) is in the middle of a two-part equity raising first announced in late June 2026. The company confirmed it had completed a A$4 million placement of 10 million new shares to institutional and sophisticated investors at A$0.40 each, reportedly a roughly …
Vitasora Health Ltd (ASX:VHL) came under pressure after its shares fell 15.39% to close at AUD 0.011 during the latest trading session. The company recorded trading turnover of approximately AUD 35,541 while maintaining a market capitalisation of around AUD 25.74 million. Over the past …
Starpharma Holdings Ltd (ASX:SPLR) came under pressure after its shares fell 15.39% to close at AUD 0.11 during the latest trading session. The company recorded trading turnover of approximately AUD 39,188 while maintaining a market capitalisation of around AUD 6.17 million. The stock is …
Nyrada Ltd (ASX:NYR) came under investor scrutiny after its shares climbed 7.14% to close at AUD 0.075 during the latest trading session. The company recorded trading turnover of approximately AUD 108,126 and maintained a market capitalisation of around AUD 20.84 million. Although the stock …
Chimeric Therapeutics Ltd (ASX:CHM) attracted market attention after its shares climbed 9.09% to close at AUD 0.048. The biotechnology company recorded trading turnover of approximately AUD 15,203 during the session and currently has a market capitalisation of around AUD 2.78 million. Although the stock …
INVEX Therapeutics Ltd (ASX:IXC) drew market attention after its shares climbed 10.00% to close at AUD 0.11. The biotechnology company recorded trading turnover of approximately AUD 15,602 during the session and currently carries a market capitalisation of around AUD 8.27 million. Over the past …
Neurotech International Ltd (ASX:NTI) emerged among the stronger performers on the Australian sharemarket after its shares rose 12.50% to close at AUD 0.018. Although turnover remained relatively modest at approximately AUD 77,660, the double-digit gain drew attention to the healthcare stock. Neurotech currently carries …